The Lead Discovery Center GmbH (LDC) transforms results from basic research into novel drug candidates. LDC collaborates with basic researchers to leverage excellent biomedical basic research. LDC's academic network represents thousands of scientists and a large pipeline of novel ideas for treating diseases with unmet medical need. LDC has established a flexible, but industry-type drug discovery infrastructure. LDC's current portfolio contains ~20 highly innovative and collaborative drug discovery projects. LDC tries to transform these innovative early-stage projects into attractive licensing opportunities. It has built up an excellent track record in partnering projects to industrial partners, like Bayer AG, Boehringer Ingelheim, Merck KGaA, Qurient etc.
[more]
